标题
AIP and the somatostatin system in pituitary tumours
作者
关键词
-
出版物
JOURNAL OF ENDOCRINOLOGY
Volume 235, Issue 3, Pages R101-R116
出版商
Bioscientifica
发表日期
2017-08-24
DOI
10.1530/joe-17-0254
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing’s disease
- (2017) Laura C Hernández-Ramírez et al. ENDOCRINE-RELATED CANCER
- Cortistatin: A new link between the growth hormone/prolactin axis, stress, and metabolism
- (2017) Alejandro Ibáñez-Costa et al. GROWTH HORMONE & IGF RESEARCH
- Role of Phosphodiesterases on the Function of Aryl Hydrocarbon Receptor-Interacting Protein (AIP) in the Pituitary Gland and on the Evaluation of AIP Gene Variants
- (2017) Laura Hernández-Ramírez et al. HORMONE AND METABOLIC RESEARCH
- In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas
- (2017) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The HSP90 chaperone machinery
- (2017) Florian H. Schopf et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Octreotide inhibits the proliferation of gastric cancer cells through P300-HAT activity and the interaction of ZAC and P300
- (2017) Liping Wang et al. ONCOLOGY REPORTS
- Novel Genetic Causes of Pituitary Adenomas
- (2016) F. Caimari et al. CLINICAL CANCER RESEARCH
- Genetic and clinical characteristics of Japanese patients with sporadic somatotropinoma
- (2016) Ryusaku Matsumoto et al. ENDOCRINE JOURNAL
- Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects
- (2016) Adrian F Daly et al. ENDOCRINE-RELATED CANCER
- Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future
- (2016) Kjell Öberg et al. ENDOCRINE-RELATED CANCER
- cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors
- (2016) Graeme B Bolger et al. ENDOCRINE-RELATED CANCER
- Impact of AIP and inhibitory G protein alpha 2 proteins on clinical features of sporadic GH-secreting pituitary adenomas
- (2016) Elina Ritvonen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With MissenseAIPMutations
- (2016) Laura C. Hernández-Ramírez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cellsin vitro
- (2016) Alejandro Ibáñez-Costa et al. JOURNAL OF ENDOCRINOLOGY
- Characterization ofGPR101transcript structure and expression patterns
- (2016) Giampaolo Trivellin et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Predictive value of T2 relative signal intensity for response to somatostatin analogs in newly diagnosed acromegaly
- (2016) Ming Shen et al. NEURORADIOLOGY
- Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study
- (2016) Donato Iacovazzo et al. Acta Neuropathologica Communications
- Molecular Mechanisms Underlying Pituitary Pathogenesis
- (2015) Melanie Sapochnik et al. BIOCHEMICAL GENETICS
- Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas
- (2015) Raúl M. Luque et al. CANCER LETTERS
- Recurrent gain-of-function USP8 mutations in Cushing's disease
- (2015) Zeng-Yi Ma et al. CELL RESEARCH
- Treatment of acromegaly in the era of personalized and predictive medicine
- (2015) Manuel Puig Domingo CLINICAL ENDOCRINOLOGY
- GHRH excess and blockade in X-LAG syndrome
- (2015) Adrian F Daly et al. ENDOCRINE-RELATED CANCER
- X-linked acrogigantism syndrome: clinical profile and therapeutic responses
- (2015) A. Beckers et al. ENDOCRINE-RELATED CANCER
- Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences
- (2015) I. Potorac et al. ENDOCRINE-RELATED CANCER
- Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study
- (2015) Donato Iacovazzo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis inAIPMutation Carriers
- (2015) Laura C. Hernández-Ramírez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
- (2015) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Human somatostatin receptor-3 distinctively induces apoptosis in MCF-7 and cell cycle arrest in MDA-MB-231 breast cancer cells
- (2015) Sajad A. War et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Differential somatostatin receptor (SSTR) 1–5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors
- (2015) Katja Kiseljak-Vassiliades et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
- (2015) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: a meta-analysis
- (2015) Z. A. Efstathiadou et al. Pituitary
- Molecular Characterization of Growth Hormone-producing Tumors in the GC Rat Model of Acromegaly
- (2015) Juan F. Martín-Rodríguez et al. Scientific Reports
- Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement
- (2015) Erika Peverelli et al. Frontiers in Endocrinology
- Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas
- (2015) Judit Dénes et al. PLoS One
- SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary
- (2014) Misu Lee et al. ENDOCRINE-RELATED CANCER
- MicroRNAs: Suggested role in pituitary adenoma pathogenesis
- (2014) M. R. Gadelha et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Somatostatin receptor ligands and resistance to treatment in pituitary adenomas
- (2014) Daniel Cuevas-Ramos et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Epidemiology and etiopathogenesis of pituitary adenomas
- (2014) Elena D. Aflorei et al. JOURNAL OF NEURO-ONCOLOGY
- Constitutive Somatostatin Receptor Subtype-3 Signaling Suppresses Growth Hormone Synthesis
- (2014) Tamar Eigler et al. MOLECULAR ENDOCRINOLOGY
- Mutations in the deubiquitinase gene USP8 cause Cushing's disease
- (2014) Martin Reincke et al. NATURE GENETICS
- Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation
- (2014) Giampaolo Trivellin et al. NEW ENGLAND JOURNAL OF MEDICINE
- AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling
- (2014) I Tuominen et al. ONCOGENE
- Somatostatin Analog Inhibits the Growth of Insulinoma Cells by p27-Mediated G1 Cell Cycle Arrest
- (2014) Takeshi Aoki et al. PANCREAS
- δ-Opioid Receptor and Somatostatin Receptor-4 Heterodimerization: Possible Implications in Modulation of Pain Associated Signaling
- (2014) Rishi K. Somvanshi et al. PLoS One
- A long-term follow-up study of eighteen patients with thyrotrophin-secreting pituitary adenomas
- (2013) Nadège C. van Varsseveld et al. CLINICAL ENDOCRINOLOGY
- Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies
- (2013) Federica Barbieri et al. DRUG DISCOVERY TODAY
- Effective Long-Term Treatment of Cushing's Disease with Pasireotide: A Case Report
- (2013) Lin Lu et al. Endocrine Practice
- Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations
- (2013) Marie-Lise Jaffrain-Rea et al. ENDOCRINE-RELATED CANCER
- Constitutive Somatostatin Receptor Subtype 2 Activity Attenuates GH Synthesis
- (2013) Anat Ben-Shlomo et al. ENDOCRINOLOGY
- β-Arrestin 1 and 2 and G Protein-Coupled Receptor Kinase 2 Expression in Pituitary Adenomas: Role in the Regulation of Response to Somatostatin Analogue Treatment in Patients With Acromegaly
- (2013) Federico Gatto et al. ENDOCRINOLOGY
- Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naïve patients with somatotroph adenomas
- (2013) Sarah Larkin et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas
- (2013) Bernhard Mayr et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Somatostatin receptors: From signaling to clinical practice
- (2013) Marily Theodoropoulou et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies
- (2013) Laura Chinezu et al. HUMAN PATHOLOGY
- Preoperative Normalization of Cortisol Levels in Cushing's Disease After Medical Treatment: Consequences for Somatostatin and Dopamine Receptor Subtype Expression and In Vitro Response to Somatostatin Analogs and Dopamine Agonists
- (2013) R. van der Pas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide
- (2013) Olivera Casar-Borota et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics
- (2013) Linn Fagerberg et al. MOLECULAR & CELLULAR PROTEOMICS
- Managing hyperglycemia in patients with Cushing’s disease treated with pasireotide: medical expert recommendations
- (2013) Annamaria Colao et al. Pituitary
- Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal α-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition
- (2013) Rhodri M. L. Morgan et al. PLoS One
- ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas
- (2013) Leonardo Vieria Neto et al. PLoS One
- MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro
- (2012) Giampaolo Trivellin et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- NMR assignments of the FKBP-type PPIase domain of the human aryl-hydrocarbon receptor-interacting protein (AIP)
- (2012) Miriam Linnert et al. Biomolecular NMR Assignments
- Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas
- (2012) C.B. Murat et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression
- (2012) Leandro Kasuki et al. ENDOCRINE-RELATED CANCER
- Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues
- (2012) Josep Oriola et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Specific roles of Gi protein family members revealed by dissecting SST5 coupling in human pituitary cells
- (2012) E. Peverelli et al. JOURNAL OF CELL SCIENCE
- Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway
- (2012) Harvinder S. Chahal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly
- (2012) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin analogs and chimeric somatostatin–dopamine molecules differentially regulate human growth hormone and prolactin gene expression and secretion in vitro
- (2012) Anna Gruszka et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: Impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion
- (2012) Thomas Cuny et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Negative Regulation of Pancreatic and Duodenal Homeobox-1 by Somatostatin Receptor Subtype 5
- (2012) Guisheng Zhou et al. MOLECULAR ENDOCRINOLOGY
- Reassessment of sst3Somatostatin Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-5
- (2012) Amelie Lupp et al. NEUROENDOCRINOLOGY
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
- (2012) Annamaria Colao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience
- (2012) Jessica Brzana et al. Pituitary
- Novel pathway for somatostatin analogs in patients with acromegaly
- (2012) Mônica R. Gadelha et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- A first-in-man study to evaluate the safety, tolerability, and pharmacokinetics of pasireotide (SOM230), a multireceptor-targeted somatostatin analog, in healthy volunteers
- (2012) Georg Golor et al. Drug Design Development and Therapy
- Somatostatinergic systems: an update on brain functions in normal and pathological aging
- (2012) Guillaume Martel et al. Frontiers in Endocrinology
- Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly
- (2011) Stine Lyngvi Fougner et al. CLINICAL ENDOCRINOLOGY
- Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins
- (2011) Federico Gatto et al. CLINICAL ENDOCRINOLOGY
- Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly
- (2011) Ansgar Heck et al. CLINICAL ENDOCRINOLOGY
- Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas
- (2011) Masako Kato et al. ENDOCRINE JOURNAL
- Resistance to Somatostatin Analogs in Acromegaly
- (2011) Annamaria Colao et al. ENDOCRINE REVIEWS
- AIP and its interacting partners
- (2011) Giampaolo Trivellin et al. JOURNAL OF ENDOCRINOLOGY
- Somatostatin Dramatically Stimulates Growth Hormone Release from Primate Somatotrophs Acting at Low Doses Via Somatostatin Receptor 5 and Cyclic AMP
- (2011) J. Córdoba-Chacón et al. JOURNAL OF NEUROENDOCRINOLOGY
- Medical treatment of prolactinomas
- (2011) Annamaria Colao et al. Nature Reviews Endocrinology
- Somatostatin and its receptors from fish to mammals
- (2010) Manuel D. Gahete et al. Annals of the New York Academy of Sciences
- Pasireotide for the treatment of Cushing's disease
- (2010) Giorgio Arnaldi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1 - molecular pathways
- (2010) Mehtap Cakir et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Magnetic Resonance Imaging as a Predictor of Response to Somatostatin Analogs in Acromegaly after Surgical Failure
- (2010) Manel Puig-Domingo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Potential Inhibitory Role for the New Truncated Variant of Somatostatin Receptor 5, sst5TMD4, in Pituitary Adenomas Poorly Responsive to Somatostatin Analogs
- (2010) Mario Durán-Prado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study
- (2010) Adrian F. Daly et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ZAC1 target genes and pituitary tumorigenesis
- (2010) Marily Theodoropoulou et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Pituitary tumours: The sst/D2 receptors as molecular targets
- (2010) Leo J. Hofland et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- HSP90 at the hub of protein homeostasis: emerging mechanistic insights
- (2010) Mikko Taipale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Impact of gsp Oncogene on the mRNA Content for Somatostatin and Dopamine Receptors in Human Somatotropinomas
- (2010) Giselle Fernandes Taboada et al. NEUROENDOCRINOLOGY
- Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas than Ki-67 and p53
- (2010) Leandro Kasuki Jomori de Pinho et al. NEUROENDOCRINOLOGY
- Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
- (2010) Richard A. Feelders et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pituitary somatostatin receptor signaling
- (2010) Anat Ben-Shlomo et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- G-protein signalling negatively regulates the stability of aryl hydrocarbon receptor
- (2009) Asuka Nakata et al. EMBO REPORTS
- Differential Expression of Somatostatin and Dopamine Receptor Subtype Genes in Adrenocorticotropin (ACTH)-secreting Pituitary Tumors and Silent Corticotroph Adenomas
- (2009) Toru TATENO et al. ENDOCRINE JOURNAL
- Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications
- (2009) Marie-Lise Jaffrain-Rea et al. ENDOCRINE-RELATED CANCER
- XAP2 inhibits glucocorticoid receptor activity in mammalian cells
- (2009) Anna Laenger et al. FEBS LETTERS
- Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly
- (2009) Marily Theodoropoulou et al. INTERNATIONAL JOURNAL OF CANCER
- Predicting Recurrence of Nonfunctioning Pituitary Adenomas
- (2009) Tae-Woong Noh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
- (2009) Christiaan de Bruin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
- (2009) Leonardo Vieira Neto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification and Characterization of Two Novel Truncated but Functional Isoforms of the Somatostatin Receptor Subtype 5 Differentially Present in Pituitary Tumors
- (2009) Mario Durán-Prado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly pathogenesis and treatment
- (2009) Shlomo Melmed JOURNAL OF CLINICAL INVESTIGATION
- Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas
- (2008) J. Acunzo et al. CANCER RESEARCH
- Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas: Difference among Various Types Defined by Cytokeratin Distribution Pattern Including a Transitional Form
- (2008) Abdulkader Obari et al. ENDOCRINE PATHOLOGY
- Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study
- (2008) T. Florio et al. ENDOCRINE-RELATED CANCER
- Medical therapy for clinically non-functioning pituitary adenomas
- (2008) A. Colao et al. ENDOCRINE-RELATED CANCER
- Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors
- (2008) Yong Lin et al. ENDOCRINE-RELATED CANCER
- Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR
- (2008) Giselle F Taboada et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas
- (2008) Alessandra Fusco et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pathology of the human pituitary adenomas
- (2008) Robert Y. Osamura et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Correlation ofin Vitroandin VivoSomatotropic Adenoma Responsiveness to Somatostatin Analogs and Dopamine Agonists with Immunohistochemical Evaluation of Somatostatin and Dopamine Receptors and Electron Microscopy
- (2008) Diego Ferone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas
- (2008) Chrysanthia A. Leontiou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro
- (2008) C de Bruin et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Cell Growth Inhibition and Functioning of Human Somatostatin Receptor Type 2 Are Modulated by Receptor Heterodimerization
- (2008) Michael Grant et al. MOLECULAR ENDOCRINOLOGY
- Dimerization of G protein-coupled receptors: New avenues for somatostatin receptor signalling, control and functioning
- (2007) Mario Durán-Prado et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Are somatostatin and cortistatin two siblings in regulating endocrine secretions? In vitro work ahead
- (2007) Manuel D. Gahete et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started